Classifications

• • A—HUMAN NECESSITIES
  • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
  • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
  • A23C9/00—Milk preparations; Milk powder or milk powder preparations
  • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
  • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
  • A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
• • A—HUMAN NECESSITIES
  • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
  • A23K—FODDER
  • A23K10/00—Animal feeding-stuffs
  • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
  • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
  • A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
• • A—HUMAN NECESSITIES
  • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
  • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
  • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
  • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
  • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
• • C—CHEMISTRY; METALLURGY
  • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
  • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
  • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
  • C12N1/20—Bacteria; Culture media therefor
• • C—CHEMISTRY; METALLURGY
  • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
  • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
  • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
  • C12N1/20—Bacteria; Culture media therefor
  • C12N1/205—Bacterial isolates
• • A—HUMAN NECESSITIES
  • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
  • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
  • A23V2400/00—Lactic or propionic acid bacteria
  • A23V2400/11—Lactobacillus
  • A23V2400/123—Bulgaricus
• • A—HUMAN NECESSITIES
  • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
  • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
  • A23V2400/00—Lactic or propionic acid bacteria
  • A23V2400/11—Lactobacillus
  • A23V2400/143—Fermentum
• • A—HUMAN NECESSITIES
  • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
  • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
  • A23V2400/00—Lactic or propionic acid bacteria
  • A23V2400/11—Lactobacillus
  • A23V2400/165—Paracasei
• • A—HUMAN NECESSITIES
  • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
  • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
  • A23V2400/00—Lactic or propionic acid bacteria
  • A23V2400/11—Lactobacillus
  • A23V2400/175—Rhamnosus
• • A—HUMAN NECESSITIES
  • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
  • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
  • A23V2400/00—Lactic or propionic acid bacteria
  • A23V2400/21—Streptococcus, lactococcus
  • A23V2400/249—Thermophilus
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
  • A61K35/66—Microorganisms or materials therefrom
  • A61K35/74—Bacteria
  • A61K35/741—Probiotics
  • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
  • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
• • C—CHEMISTRY; METALLURGY
  • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
  • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
  • C12R2001/00—Microorganisms ; Processes using microorganisms
  • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
  • C12R2001/225—Lactobacillus

Definitions

• the present invention relates Lactobacillus fermentum bacteria having the ability to reduce the concentration of acetaldehyde produced by a starter culture during fermentation in a fermented milk product, compositions comprising the bacteria, in particular adjunct cultures comprising the bacteria, methods of producing a fermented milk product using the bacteria or the cultures and the fermented milk products thus obtained, including food, feed and pharmaceutical products.
• Lactic acid bacteria have been used over decades for increasing the shelf life of food products. During fermentation LAB produce lactic acids as well as other organic acids which cause a reduction of pH of the fermented product. Products having an acidic pH do not support further growth of most microorganisms, including pathogenic and spoilage organisms.
• yoghurt is produced by fermentation of milk with a specific yoghurt starter culture consisting of a mixture of two species of lactic acid bacteria (LAB), Lactobacillus delbrueckii subsp. bulgaricus and Streptococcus thermophilus.
• the main roles of the starter in the production of yoghurt are (i) acidification through the conversion of lactose into lactic acid, (ii) creation of viscous texture e.g. by denaturation of proteins and production of exopolysaccharides, and (iii) development of the typical yoghurt flavor (1).
• the typical yoghurt flavor is caused by lactic acid, which imparts an acidic and refreshing taste, and a mixture of various carbonyl compounds like acetone, diacetyl, and acetaldehyde, the latter of which is considered the major flavor component (2).
• the relatively high concentration of acetaldehyde found in yoghurt is suspected to be due to a low utilization rate of this metabolite since the common yoghurt bacteria lack the main enzyme for acetaldehyde conversion into ethanol, alcohol dehydrogenase (3).
• acetaldehyde can be produced directly from lactose metabolism as a result of pyruvate decarboxylation. It can be produced (i) directly via pyruvate decarboxylase or pyruvate oxidase or (ii) indirectly through the formation of the intermediate acetyl coenzyme A by pyruvate dehydrogenase or pyruvate formate lyase. Furthermore, acetaldehyde can be formed by the activity of deoxyriboaldolase, which degrades thymidine into acetaldehyde and glyceraldehyde-3-phosphate.
• threonine can be directly converted into acetaldehyde and glycine by the activity of threonine aldolase (TA).
• TA threonine aldolase
• the Lactobacillus fermentum strains of the present invention is characterized in having the ability to reduce the concentration of acetaldehyde produced by a starter culture during fermentation in a fermented milk product by at least 50%.
• the present invention provides the bacteria as described above, compositions comprising the same, methods using the bacteria for producing fermented milk products, as well as the products thus obtained.
• the present invention provides a bacterium of the species Lactobacillus fermentum having the ability to reduce the concentration of acetaldehyde produced by a starter culture during fermentation in a fermented milk product by at least 50%. The reduction is determined in comparison to a fermented product produced without the Lactobacillus fermentum strains of the present invention.
• Different assays are known in the art for determining the concentration of acetaldehyde in a fermented product and can be used for that purpose in accordance with the present invention.
• the ability to reduce the concentration of acetaldehyde produced by a starter culture during fermentation in a fermented milk product by at least 50% is preferably determined in an assay comprising:
• Acetaldehyde is a taste component produced by lactic acid bacteria during fermentation. While the component is desirable in certain applications, it would be advantageous to reduce or avoid the presence of acetaldehyde in other applications. Lactobacillus fermentum bacteria reducing the concentration of acetaldehyde in a fermented milk product therefore provide advantages in specific applications, for example when preparing sweetened or mild yoghurt.
• the Lactobacillus fermentum strains of the present invention may for example reduce the concentration of acetaldehyde produced by a starter culture during fermentation in a fermented milk product by at least 75%, at least 95% or at least 98%.
• the Lactobacillus fermentum strains of the present invention can for example be characterized in that they have the ability to reduce the concentration of acetaldehyde produced by a starter culture during fermentation in a fermented milk product by at least 50%, wherein the starter culture used for the preparation of the fermented milk product comprises LAB which are able to produce acetaldehyde in a concentration of 3 ppm or more.
• the assay may be based using a starter culture comprising Streptococcus thermophilus and Lactobacillus delbrueckii subsp. bulgaricus. Respective mixtures are frequently used for the production of yoghurt and known to produce acetaldehyde.
• (k) a mutant strain obtainable from one the deposited bacteria according to (a) to (j), wherein the mutant has the ability to reduce the concentration of acetaldehyde produced by a starter culture during fermentation in a fermented milk product by at least 50%.
• lactic acid bacteria or "LAB” is used to refer to food-grade bacteria producing lactic acid as the major metabolic end-product of carbohydrate fermentation. These bacteria are related by their common metabolic and physiological characteristics and are usually Gram positive, low-GC, acid tolerant, non- sporulating, non-respiring, rod-shaped bacilli or cocci. During the fermentation stage, the consumption of lactose by these bacteria causes the formation of lactic acid, reducing the pH and leading to the formation of a protein coagulum. These bacteria are thus responsible for the acidification of milk and for the texture of the dairy product.
• lactic acid bacteria encompasses, but is not limited to, bacteria belonging to the genus of Lactobacillus spp., Bifidobacterium spp., Streptococcus spp., Lactococcus spp., such as Lactobacillus delbrueckii subsp.
• LAB are characterized as mesophilic or thermophilic LAB.
• the term “mesophile” refers to microorganisms that thrive best at moderate temperatures.
• the term “mesophilic fermentation” herein refers to fermentation at a temperature between about 22°C and about 35°C.
• the term “mesophilic fermented milk product” refers to fermented milk products prepared by mesophilic fermentation of a mesophilic starter culture and include such fermented milk products as buttermilk, sour milk, cultured milk, smetana, sour cream and fresh cheese, such as quark, tvarog and cream cheese.
• the industrially most useful mesophilic bacteria include Lactococcus spp. and Leuconostoc spp.
• thermophile refers to microorganisms that thrive best at high temperatures.
• thermal fermentation refers to fermentation methods carried out at a temperature between about 35°C and about 45°C.
• thermophilic fermented milk product refers to fermented milk products prepared by thermophilic fermentation using a thermophilic starter culture and include such fermented milk products as set-yoghurt, stirred-yoghurt, strained yoghurt and drinking yoghurt.
• the industrially most useful thermophilic bacteria include Streptococcus spp. and Lactobacillus spp.
• the present invention encompasses methods using mesophilic and thermophilic fermentation.
• inhibit in relation to fungi, yeasts and moulds refers to a decrease in the growth or sporulation or a reduction in the number or in the concentration of fungi, yeasts and moulds, for example in food products and/or on the surface of food products comprising the bacteria of the present invention in relation to food products which do not comprise such bacteria.
• the extent of inhibition provided by the Lactobacillus fermentum bacteria of the present invention is preferably determined by growth on agar solidified fermented milk in the presence and absence of the Lactobacillus fermentum bacteria.
• mutant should be understood as a strain derived from a strain of the invention by means of e.g .
• the muta nt is a functiona lly equiva lent mutant, e.g . a muta nt that has substantially the same, or improved, properties in particula r in relation to the effect of reducing aceta ldehyde, as the deposited strain .
• Such a mutant is a part of the present i nvention .
• mutant refers to a strain obtained by su bjecting a strain of the i nvention to a ny conventiona lly used mutagenization treatment including treatment with a chemical mutagen such as ethane methane sulphonate (EMS) or N-methyl-N'-nitro-N- nitroguanidine (NTG), UV lig ht or to a sponta neously occurring mutant.
• EMS ethane methane sulphonate
• NTG N-methyl-N'-nitro-N- nitroguanidine
• UV lig ht or to a sponta neously occurring mutant.
• a mutant may have been subjected to severa l mutagenization treatments (a single treatment shou ld be u nderstood one mutagenization step followed by a screening/selection step), but it is presently preferred that no more than 20, or no more than 10, or no more tha n 5, treatments (or screening/selection steps) are carried out.
• severa l mutagenization treatments a single treatment shou ld be u nderstood one mutagenization step followed by a screening/selection step
• no more than 20, or no more than 10, or no more tha n 5 treatments (or screening/selection steps) are carried out.
• less tha n 5%, or less than 1% or even less than 0.1% of the nucleotides in the bacteria l genome have been shifted with another nucleotide, or deleted, com pared to the mother strain .
• the present invention further provides compositions com prisi ng at least one bacteriu m of the species Lactobacillus fermentum with the a bility to reduce the concentration of aceta ldehyde produced by a starter cultu re duri ng fermentation in a fermented milk product by at least 50% .
• compositions may comprise nu merous further bacteria including LABs.
• a preferred composition of the present i nvention is therefore characterized in that the composition fu rther comprises at least one fu rther bacteriu m selected from one or more of the followi ng genera a nd species Lactobacillus spp., Bifidobacterium spp. , Streptococcus spp. , Lactococcus spp., such as Lactobacillus delbrueckii subsp.
• compositions of the present invention comprise at least one bacteriu m of the species Lactobacillus fermentum with the ability to reduce the concentration of acetaldehyde produced by a starter culture during fermentation in a fermented milk product by at least 50%.
• several different strains of the Lactobacillus fermentum bacteria with the ability to reduce the concentration of acetaldehyde produced by a starter culture during fermentation in a fermented milk product by at least 50% are combined.
• these further bacteria can for example be selected from:
• Lactobacillus rhamnosus bacterium of strain CHCC15860 as deposited with the German Collection of Microorganisms and Cell Cultures (DSMZ) under accession No. DSM32092;
• Lactobacillus rhamnosus bacterium of strain CHCC5366 as deposited with the German Collection of Microorganisms and Cell Cultures (DSMZ) under accession No. DSM23035;
• Lactobacillus rhamnosus bacterium of strain CHCC12697 as deposited with the German Collection of Microorganisms and Cell Cultures (DSMZ) under accession No. DSM24616;
• Lactobacillus paracasei bacterium of strain CHCC12777 as deposited with the German Collection of Microorganisms and Cell Cultures (DSMZ) under accession No. DSM24651; and
• Lactobacillus paracasei bacterium of strain CHCC14676 as deposited with the German Collection of Microorganisms and Cell Cultures (DSMZ) under accession No. DSM25612.
• compositions of the present invention may in addition comprise numerous further components, including one or more cryoprotective compounds as well as flavoring compounds.
• starter culture refers to a culture of one or more food-grade micro-organisms, in particular lactic acid bacteria, which are responsible for the acidification of the milk base. Starter cultures may be fresh, but are most frequently frozen or freeze- dried. These products are also known as "Direct Vat Set” (DVS) cultures and are produced for direct inoculation of a fermentation vessel or vat for the production of a dairy product, such as a fermented milk product or a cheese.
• DVD Direct Vat Set
• Respective starter cultures are commercially available from numerous sources and include F-DVS YoFlex Mild 2.0, F-DVS YF-L901, FD-DVS YF-812 and F-DVS CH-1, three cultures commercially available from Chr. Hansen containing mixtures of Streptococcus thermophilus and Lactobacillus delbrueckii subsp. bulgaricus.
• the present invention therefore provides compositions in the form of a solid frozen or freeze-dried starter culture comprising lactic acid bacteria in a concentration of at least 10 9 colony forming units per g of frozen material or in a concentration of at least 10 10 colony forming units per g of frozen material or in a concentration of at least 10 11 colony forming units per g of frozen material
• compositions include a bacterium of the species Lactobacillus fermentum with the ability to reduce the concentration of acetaldehyde produced by a starter culture during fermentation in a fermented milk product by at least 50% as described above.
• the present invention provides methods of producing a fermented milk product which comprise adding the Lactobacillus fermentum bacterium with the ability to reduce the concentration of acetaldehyde produced by a starter culture during fermentation in a fermented milk product by at least 50% as described above or the composition comprising the same to milk or to a milk product and fermenting the mixture at a temperature between about 22°C and about 43°C until a pH of less than 4.6 is reached.
• milk is broadly used in its common meaning to refer to liquids produced by the mammary glands of animals or by plants.
• the milk may have been processed and the term “milk” includes whole milk, skim milk, fat-free milk, low fat milk, full fat milk, lactose-reduced milk, or concentrated milk.
• Fat-free milk is non-fat or skim milk product.
• Low-fat milk is typically defined as milk that contains from about 1% to about 2% fat. Full fat milk often contains 2% fat or more.
• milk is intended to encompass milks from different mammals and plant sources. Mammal sources of milk include, but are not limited to cow, sheep, goat, buffalo, camel, llama, mare and deer.
• Plant sources of milk include, but are not limited to, milk extracted from soy bean, pea, peanut, barley, rice, oat, quinoa, almond, cashew, coconut, hazelnut, hemp, sesame seed and sunflower seed.
• milk derived from cows is most preferably used as a starting material for the fermentation.
• milk also includes fat-reduced and/or lactose-reduced milk products. Respective products can be prepared using methods well known in the art and are commercially available (for example from Select Milk Producers Inc., Texas, USA). Lactose-reduced milk can be produced according to any method known in the art, including hydrolyzing the lactose by lactase enzyme to glucose and galactose, or by nanofiltration, electrodialysis, ion exchange chromatography and centrifugation.
• the term “mi lk product” or "mi lk base” is broad ly used in the present application to refer to a composition based on milk or milk components which can be used as a medium for growth a nd fermentation of LAB.
• the mi lk product or base comprises components derived from milk a nd a ny other component that can be used for the pu rpose of g rowing or fermenting LAB.
• the fermentation step of the process for manufactu ring fermented dairy products comprises the addition of LAB to milk.
• Fermentation processes used in production of dairy products a re well known a nd a person of ordina ry skill can select fermentation process conditions, including temperature, oxygen, amou nt and characteristics of microorganism(s) a nd fermentation time.
• the milk substrate Prior to fermentation, the milk substrate may be homogenized and pasteu rized according to methods known in the a rt.
• Homogenizing as used herein means intensive mixing to obtain a solu ble suspension or emulsion . If homogenization is performed prior to fermentation, it may be performed so as to break u p the milk fat into sma ller sizes so that it no longer sepa rates from the milk. This may be accom plished by forcing the milk at hig h pressu re th rough small orifices.
• “Pasteu rizi ng” as used herein means treatment of the milk su bstrate to reduce or eliminate the presence of live organisms, such as microorganisms.
• pasteurization is attained by maintaining a specified temperature for a specified period of time.
• the specified temperatu re is usually attained by heating .
• the temperature and duration may be selected in order to kill or inactivate certain bacteria, such as harmfu l bacteria .
• a rapid cooli ng step may follow.
• the Lactobacillus ferm entum bacteriu m with the ability to reduce the concentration of aceta ldehyde produced by a starter cultu re during fermentation in a fermented milk product by at least 50% as described a bove or the com position comprisi ng the same is added to milk or to a milk product and the mixtu re is fermented in such a man ner that;
• the concentration of the Lactobacillus fermentum bacteria reducing the concentration of acetaldehyde is at least lxlO 6 cfu/g or at least lxlO 7 cfu/g at the termination of fermentation in the fermented milk product;
• One way of achieving the concentration is using a method of producing a fermented milk product, wherein the parameters for fermentation are maintained such that the concentration of the Lactobacillus fermentum bacteria described above increases during fermentation.
• the parameters for fermentation are maintained such that the concentration of the Lactobacillus fermentum bacteria described above increases during fermentation.
• the parameters for fermentation are maintained such that the concentration of the Lactobacillus fermentum bacteria described above does not significantly decrease, for example does not decrease by more than 30%, not more than 25%, or not more than 20% during fermentation and storage.
• the invention further provides methods of producing a food, feed or pharmaceutical product obtainable by a method of producing a fermented milk product as described above and the food, feed or pharmaceutical product obtainable by this method. Fermentation is carried out to produce food products, feed products or pharmaceuticals.
• the terms "fermented milk product", “food” or “feed” product refer to products obtainable by the fermentation methods of the present invention and include cheese, yoghurt, fruit yoghurt, yoghurt beverage, strained yoghurt (Greek yoghurt, Labneh), quark, fromage frais and cream cheese.
• the term food further encompasses other fermented food products, including fermented meat, such as fermented sausages, and fermented fish products.
• cheeses are understood to encompass any cheese, including hard, semi-hard and soft cheeses, such as cheeses of the following types: Cottage, Feta, Cheddar, Parmesan, Mozzarella, Emmentaler, Danbo, Gouda, Edam, Feta-type, blue cheeses, brine cheeses, Camembert and Brie.
• the person skilled in the art knows how to convert the coagulum into cheese, methods can be found in the literature, see e.g. Kosikowski, F. V., and V. V. Mistry, "Cheese and Fermented Milk Foods", 1997, 3rd Ed. F. V. Kosikowski, L. L. C. Westport, CT.
• a cheese which has a NaCI concentration below 1.7% (w/w) is referred to as a "low-salt cheese”.
• yoghurt refers to products comprising Streptococcus thermophilus and Lactobacillus delbrueckii subsp. bulgaricus and optionally other microorganisms such as Lactobacillus delbrueckii subsp. lactis, Bifidobacterium animalis subsp. lactis, Lactococcus lactis, Lactobacillus acidophilus and Lactobacillus paracasei, or any microorganism derived therefrom.
• lactis lactis, Bifidobacterium animalis subsp. lactis, Lactococcus lactis, Lactobacillus acidophilus and Lactobacillus paracasei, or any microorganism derived therefrom.
• lactis lactis
• lactis Bifidobacterium animalis subsp. lactis
• Lactococcus lactis Lactobacillus acidophilus
• Lactobacillus paracasei or any microorganism derived therefrom
• yoghurt encompasses set yoghurt, stirred yoghurt, drinking yoghurt, Petittreu, heat treated yoghurt, strained or Greek style yoghurt characterized by a high protein level and yoghurt-like products.
• dairy raw materials e.g. Lactobacillus delbrueckii subsp. bulgaricus and Streptococcus thermophilus
• Yoghurts may optionally contain added dairy raw materials (e.g.
• the yoghurt meets the specifications for fermented milks and yoghurts of the AFNOR NF 04-600 standard and/or the codex StanA-lla- 1975 standard.
• the product In order to satisfy the AFNOR NF 04-600 standard, the product must not have been heated after fermentation and the dairy raw materials must represent a minimum of 70% (m/m) of the finished product.
• the present invention provides food, feed or pharmaceutical products comprising one or more bacteria of the species Lactobacillus fermentum with the ability to reduce the concentration of acetaldehyde produced by a starter culture during fermentation in a fermented milk product by at least 50% as described above and one or more of:
• At least one further bacterium selected from one or more of the following genera Lactococcus spp., Streptococcus spp., Lactobacillus spp., Leuconostoc spp., Pseudoleuconostoc spp., Pediococcus spp., Brevibacterium spp. and Enterococcus spp.;
• Figure 1 Acetaldehyde levels after storage at 7 ⁇ 1°C for 14 days in fermented milk products fermented with starter culture alone (Reference), or starter cultures in combination with Lb. fermentum strains.
• LOD Limit of detection.
• LOQ Limit of quantification.
• Figure 2 Acetaldehyde levels after storage at 7 ⁇ 1°C for 14 days in fermented milk products fermented with starter culture alone (Reference), or starter cultures in combination with Lb. fermentum CHCC14591.
• LOD Limit of detection.
• LOQ Limit of quantification.
• Figure 3 Acidification curves of four commercial starter cultures, FD-DVS YF-L812, F-DVS
• Figure 4 Post-acidification curves of yoghurt fermented with one of four commercial starter cultures, FD-DVS YF-L812, F-DVS YF-L901, F-DVS YoFlex Mild 2.0 and F-DVS CH-1 after storage at 6°C for up to 43 days.
• Figure 5 Acetaldehyde levels after storage at 7 ⁇ 1°C for 14 days in fermented milk products fermented with starter culture, FD DVS YF-L812 or F-DVS CH-1, alone (Reference), or starter cultures in combination one of the nine Lb. fermentum strains.
• LOD Limit of detection.
• LOQ Limit of quantification.
• Reduced-fat (1.5% w/v) homogenized milk was heat-treated at 90 ⁇ 1°C for 20 min and cooled immediately.
• a commercial starter culture F-DVS YF-L901 Yo-Flex®
• F-DVS YF-L901 Yo-Flex® was inoculated at 0.02% (v/w), and the inoculated milk was distributed into 200 ml bottles.
• Ten bottles were inoculated with the Lb. fermentum strains in concentrations of 1 x 10 7 CFU/g and one bottle was used as a reference and only inoculated with the starter culture. All bottles were incubated in a water bath at 43 ⁇ 1°C and fermented at these conditions until pH of 4.60 ⁇ 0.1 was reached.
• HSGC static head space gas chromatography
• HS-software HSControl v.2.00, Perkin Elmer.
• HSGC static head space gas chromatography
• HS-autosampler HS40XI, TurboMatrix 110, Perkin Elmer.
• HS-software HSControl v.2.00, Perkin Elmer.
• Lb. fermentum 14591 has the ability to reduce the concentration of acetaldehyde produced by a starter culture during fermentation in a fermented milk product.
• the three commercial starter cultures included herein were chosen based on their different acidification profiles. Three were frozen, F-DVS CH-1, F-DVS YoFlex Mild 2.0 and F-DVS YF- L901, and one was freeze dried, FD-DVS YF-L812. To test the difference in acidification profiles, semi fat milk was standardized to 1% fat and 4.5% protein with skim milk powder and heat-treated at 85 ⁇ 1°C for 30 min and cooled immediately.
• Reduced-fat (1.5% w/v) homogenized milk was heat-treated at 90 ⁇ 1°C for 20 min and cooled immediately.
• Milk was inoculated with one of two commercial starter cultures (F-DVS CH-1 or FD-DVS YF-L812) at 0.02% (v/w), and the inoculated milk was distributed into 200 ml bottles.
• Nine bottles were inoculated with the Lb. fermentum strains in concentrations of 1 x 10 7 CFU/g and one bottle inoculated with each starter culture was used as a reference and only inoculated with the starter culture. All bottles were incubated in a water bath at 43 ⁇ 1°C and fermented at these conditions until pH of 4.55 ⁇ 0.1 was reached. After fermentation, the bottles were vigorously shaken to break the coagulum and cooled on ice. The bottles were stored at 7 ⁇ 1°C for 14 days.
• the tested Lb. fermentum strains were: Lb. fermentum CHCC12798, Lb. fermentum
• HSGC static head space gas chromatography
• HS-autosampler HS40XI, TurboMatrix 110, Perkin Elmer.
• HS-software HSControl v.2.00, Perkin Elmer.
• Lactobacillus fermentum strain CHCC12798 was deposited at German Collection of Microorganisms and Cell Cultures (Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH; DSMZ), Inhoffenstr. 7B, D-38124 Braunschweig deposited on 2015-07-16 under the accession No.: 32084.
• Lactobacillus fermentum strain CHCC12797 was deposited at German Collection of Microorganisms and Cell Cultures (Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH; DSMZ), Inhoffenstr. 7B, D-38124 Braunschweig deposited on 2015-07-16 under the accession No.: 32085.
• Lactobacillus fermentum strain CHCC14591 was deposited at German Collection of Microorganisms and Cell Cultures (Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH; DSMZ), Inhoffenstr. 7B, D-38124 Braunschweig deposited on 2015-07-16 under the accession No.: 32086.
• Lactobacillus fermentum strain CHCC14588 was deposited at German Collection of Microorganisms and Cell Cultures (Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH; DSMZ), Inhoffenstr. 7B, D-38124 Braunschweig deposited on 2015-07-16 under the accession No.: 32087.
• Lactobacillus fermentum strain CHCC15844 was deposited at German Collection of Microorganisms and Cell Cultures (Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH; DSMZ), Inhoffenstr. 7B, D-38124 Braunschweig deposited on 2015-07-16 under the accession No.: 32088.
• Lactobacillus fermentum strain CHCC15865 was deposited at German Collection of Microorganisms and Cell Cultures (Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH; DSMZ), Inhoffenstr. 7B, D-38124 Braunschweig deposited on 2015-07-16 under the accession No.: 32089.
• Lactobacillus fermentum strain CHCC15847 was deposited at German Collection of Microorganisms and Cell Cultures (Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH; DSMZ), Inhoffenstr. 7B, D-38124 Braunschweig deposited on 2015-07-16 under the accession No.: 32090.
• Lactobacillus fermentum strain CHCC15848 was deposited at German Collection of Microorganisms and Cell Cultures (Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH; DSMZ), Inhoffenstr. 7B, D-38124 Braunschweig deposited on 2015-07-16 under the accession No.: 32091.
• Lactobacillus fermentum strain CHCC15926 was deposited at German Collection of Microorganisms and Cell Cultures (Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH; DSMZ), Inhoffenstr. 7B, D-38124 Braunschweig deposited on 2015-07-22 under the accession No.: 32096.
• Lactobacillus fermentum strain CHCC2008 was deposited at German Collection of Microorganisms and Cell Cultures (Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH; DSMZ), Inhoffenstr. 7B, D-38124 Braunschweig deposited on 2009-05-19 under the accession No.: 22584.
• Lactobacillus rhamnosus strain CHCC15860 was deposited at German Collection of Microorganisms and Cell Cultures (Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH; DSMZ), Inhoffenstr. 7B, D-38124 Braunschweig deposited on 2015-07-16 under the accession No.: 32092.

Landscapes

• Life Sciences & Earth Sciences (AREA)
• Chemical & Material Sciences (AREA)
• Engineering & Computer Science (AREA)
• Health & Medical Sciences (AREA)
• Microbiology (AREA)
• Zoology (AREA)
• Biotechnology (AREA)
• Polymers & Plastics (AREA)
• Organic Chemistry (AREA)
• Wood Science & Technology (AREA)
• Genetics & Genomics (AREA)
• Bioinformatics & Cheminformatics (AREA)
• Food Science & Technology (AREA)
• Biomedical Technology (AREA)
• Biochemistry (AREA)
• Medicinal Chemistry (AREA)
• General Health & Medical Sciences (AREA)
• Mycology (AREA)
• General Engineering & Computer Science (AREA)
• Tropical Medicine & Parasitology (AREA)
• Virology (AREA)
• Molecular Biology (AREA)
• Animal Husbandry (AREA)
• Physiology (AREA)
• Nutrition Science (AREA)
• Pharmacology & Pharmacy (AREA)
• Epidemiology (AREA)
• Animal Behavior & Ethology (AREA)
• Public Health (AREA)
• Veterinary Medicine (AREA)
• Micro-Organisms Or Cultivation Processes Thereof (AREA)
• Dairy Products (AREA)
• Fodder In General (AREA)
• Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Priority Applications (11)

Applications Claiming Priority (2)

Publications (1)

Family

ID=54014674

Family Applications (1)

Country Status (14)

Cited By (2)

Families Citing this family (6)

Citations (2)

Family Cites Families (5)

• 2016
  • 2016-08-30 MX MX2018002307A patent/MX2018002307A/es unknown
  • 2016-08-30 KR KR1020187008644A patent/KR20180042408A/ko not_active Withdrawn
  • 2016-08-30 PE PE2018000328A patent/PE20181134A1/es unknown
  • 2016-08-30 WO PCT/EP2016/070408 patent/WO2017037058A1/en not_active Ceased
  • 2016-08-30 EP EP16758166.9A patent/EP3344051A1/en not_active Withdrawn
  • 2016-08-30 AU AU2016315145A patent/AU2016315145A1/en not_active Abandoned
  • 2016-08-30 CN CN201680061156.8A patent/CN108135194A/zh active Pending
  • 2016-08-30 BR BR112018003474A patent/BR112018003474A2/pt not_active IP Right Cessation
  • 2016-08-30 EA EA201890407A patent/EA201890407A1/ru unknown
  • 2016-08-30 JP JP2018510840A patent/JP2018533910A/ja active Pending
  • 2016-08-30 US US15/755,038 patent/US20180235249A1/en not_active Abandoned
  • 2016-08-31 AR ARP160102651A patent/AR105868A1/es unknown
• 2018
  • 2018-02-14 ZA ZA2018/00997A patent/ZA201800997B/en unknown
  • 2018-02-22 IL IL257684A patent/IL257684A/en unknown

Patent Citations (2)

Also Published As

Similar Documents

Legal Events